Orchid, MPI Dodge Enzo Biochem's Patent, Contract Claims

Law360, New York (December 09, 2013, 4:26 PM ET) -- A New York federal judge on Friday tossed Enzo Biochem Inc.'s breach of contract, unfair competition and patent claims against two biotechnology companies over their use of its patented technology for labeling nucleotides, the basic building blocks of DNA, after finding Enzo could not back up its accusations.

U.S. District Judge Richard Sullivan said there was no proof that Orchid Biosciences Inc. and Molecular Probes Inc. — which Enzo hit with separate suits along with several other companies over their use of its products — were...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required